From: The impact of native Fallot anatomy on future therapeutic requirements and outcomes at follow-up
Total (178) | Group 1 (52) | Group 2 (85) | Group 3 (41) | P | |
---|---|---|---|---|---|
Adverse cardiac event, n (%) | 4 (2.2) | 0 | 3 (3.5) | 1 (2.5) | 0.3 |
Pt underwent postop. procedure, n (%) | 41 (23) | 3 (5.8) | 16 (19.5) | 22 (55) | < 0.0001 |
F-up from primary repair, years (IQR) | 10.1 (4.5–15.1) | 11.4 (5–16.9) | 9.5 (4.7–15) | 9.9 (2.4–14.7) | 0.3 |
Type of first procedure, n (%) | 0.4 | ||||
-Surgical | 26 (63.4) | 2 (66.7) | 12 (75) | 12 (54.5) | |
-Interventional | 15 (36.6) | 1 (33.3) | 4 (25) | 10 (45.5) | |
Number of procedures per pt | 0.3 (0–4) | 0.07 (0–1) | 0.24 (0–2) | 0.87(0–4) | < 0.001 |
-1 (%) | 31 (18) | 3 (5.8) | 15 (18.5) | 13 (32.5) | |
-2 (%) | 5 (2.9) | 0 | 2 (2.5) | 3 (7.5) | |
-3 (%) | 4 (2.3) | 0 | 0 | 4 (10) | |
-4 (%) | 1 (0.6) | 0 | 0 | 1 (2.5) | |
Interventional procedure, n (%) | 21(12.2) | 1 (2) | 5 (6.2) | 15 (37.5) | < 0.001 |
-Angioplasty/stent PAs | 14 | 1 | 2 | 11 | |
-Stent RVOT | 3 | 0 | 2 | 1 | |
-Others | 4 | 0 | 1 | 3 | |
Surgical procedures, n (%) | 30 (17) | 3 (5.5) | 11 (13) | 16 (40) | 0.006 |
-RVOT muscle resection/patch enlargement | 8 | 2 | 5 | 1 | |
-PVR + RVOT + PAs patch enlargement | 3 | 0 | 0 | 3 | |
-RVOT + PAs patch enlargement | 2 | 0 | 1 | 1 | |
-PVR/ RV-PA conduit implant | 14 | 1 | 5 | 8 | |
-PAs patch enlargement | 3 | 0 | 0 | 3 |